UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
CALL
ExxonMobil
XOM
$644B
| $43.6M | 0.02% |
625,500
+257,200
| +70% | +$17.8M |
|
852
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
| $43.6M | 0.02% |
1,073,987
+424,849
| +65% | +$16.4M |
|
853
Nuveen Quality Municipal Income Fund
NAD
$2.74B
| $43.4M | 0.02% |
2,973,942
+182,252
| +7% | +$2.64M |
|
854
JPMorgan Diversified Return International Equity ETF
JPIN
$368M
| $43.4M | 0.02% |
760,380
-126,258
| -14% | -$6.98M |
|
855
Allegion
ALLE
$13.4B
| $43.2M | 0.02% |
346,831
-97,558
| -22% | -$11.3M |
|
856
Amphenol
APH
$198B
| $43M | 0.02% |
1,589,584
+571,536
| +56% | +$14.6M |
|
|
PMT
857
PennyMac Mortgage Investment
PMT
$822M
| $42.9M | 0.01% |
1,923,828
-389,663
| -17% | -$8.82M |
|
858
CALL
Biogen
BIIB
$30B
| $42.9M | 0.01% |
144,500
+144,275
| +64,122% | +$40M |
|
859
Bain Capital Specialty
BCSF
$806M
| $42.9M | 0.01% |
2,210,813
-36,942
| -2% | -$695K |
|
|
860
PUT
Biogen
BIIB
$30B
| $42.8M | 0.01% |
144,400
-6,200
| -4% | -$1.72M |
|
861
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
| $42.6M | 0.01% |
1,080,056
+59,287
| +6% | +$2.27M |
|
862
BlackRock Multi-Sector Income Trust
BIT
$698M
| $42.4M | 0.01% |
2,625,870
-91,298
| -3% | -$1.55M |
|
863
Southwest Airlines
LUV
$22B
| $42.4M | 0.01% |
785,933
+20,937
| +3% | +$1.16M |
|
864
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.2B
| $42.3M | 0.01% |
1,349,921
-77,787
| -5% | -$2.37M |
|
865
PUT
iShares Biotechnology ETF
IBB
$9.34B
| $42.3M | 0.01% |
351,000
-134,000
| -28% | -$15M |
|
866
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
| $41.9M | 0.01% |
1,554,760
-181,389
| -10% | -$4.86M |
|
867
TripAdvisor
TRIP
$1.65B
| $41.7M | 0.01% |
1,371,672
+1,047,032
| +323% | +$35.2M |
|
868
Marathon Petroleum
MPC
$92.4B
| $41.5M | 0.01% |
688,836
-2,274,697
| -77% | -$142M |
|
869
Monster Beverage
MNST
$94.3B
| $41.4M | 0.01% |
1,303,652
+349,246
| +37% | +$10.3M |
|
870
Lincoln National
LNC
$8.73B
| $41.4M | 0.01% |
701,942
-54,024
| -7% | -$3.18M |
|
|
IAA
871
DELISTED
IAA, Inc. Common Stock
IAA
| $41.4M | 0.01% |
879,764
+825,300
| +1,515% | +$34.7M |
|
|
VMW
872
DELISTED
VMware, Inc
VMW
| $41.4M | 0.01% |
272,743
+55,760
| +26% | +$8.74M |
|
873
CALL
Starbucks
SBUX
$120B
| $41.4M | 0.01% |
470,600
+61,900
| +15% | +$5.28M |
|
|
IBDO
874
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $41.3M | 0.01% |
1,615,042
+214,910
| +15% | +$5.49M |
|
875
Regions Financial
RF
$26.4B
| $41.3M | 0.01% |
2,404,616
+963,960
| +67% | +$15.9M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.